Luminelle

Executive Summary

Luminelle, a subsidiary of UVision360, is a medical device company focused on advancing women's health through its Luminelle DTx Hysteroscopy System. This fully integrated, office-based platform is designed to shift diagnostic and therapeutic uterine procedures from traditional hospital surgical centers to more cost-effective and convenient office settings. By enabling hysteroscopy in the office, Luminelle aims to reduce healthcare costs, improve patient access, and enhance the overall experience for women undergoing these common procedures. The company operates in the growing digital health and women's health markets, addressing a significant unmet need for less invasive, more accessible gynecological care. With its commercialized product, Luminelle is positioned to capture market share as healthcare providers increasingly adopt office-based solutions. Luminelle's strategy aligns with the broader trend toward decentralized care and value-based medicine. While the company has already commercialized its system, ongoing efforts to expand clinical evidence, secure reimbursement, and form strategic partnerships will be critical for scaling adoption. The DTx Hysteroscopy System represents a meaningful innovation in women's health, with potential to improve clinical outcomes and operational efficiency. As the company continues to gain traction, its ability to demonstrate clinical and economic value will determine its success in a competitive landscape. Luminelle's focus on office-based hysteroscopy positions it well for growth, especially as payors and providers seek cost-saving alternatives.

Upcoming Catalysts (preview)

• Q4 2026Publication of key clinical study demonstrating office-based hysteroscopy outcomes70% success
• Q2 2027Strategic partnership with a major healthcare distributor or group purchasing organization50% success
• H2 2027Expansion of reimbursement coverage from major commercial payors60% success